학술논문
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial
Document Type
Article
Author
Tolaney, S.M.; Tarantino, P.; DeMeo, M.; DiLullo, M.; Zanudo, J.G.T.; Wagle, N.; Partridge, A.H.; Waks, A.G.; Krop, I.E.; Burstein, H.J.; Winer, E.P.; Graham, N.; Tayob, N.; Parè, L.; Villacampa, G.; Villagrasa, P.; Prat, A.; Dang, C.T.; Hudis, C.A.; Yardley, D.A.; Moy, B.; Marcom, P.K.; Albain, K.S.; Rugo, H.S.; Ellis, M.J.; Shapira, I.; Wolff, A.C.; Carey, L.A.; Barroso-Sousa, R.; Weiss, J.
Source
In: The Lancet Oncology . (The Lancet Oncology, March 2023, 24(3):273-285)
Subject
Language
English
ISSN
14745488
14702045
14702045